Events 7th International Electronic Conference on Medicinal Chemistry

Event submissions

Published

10.3390/ECMC2021-11459

This submission belongs to the session S6. Round table on predictive tools of the event 7th International Electronic Conference on Medicinal Chemistry

Published date

03 Nov, 2021

Academic Editor

Jean Jacques Vanden Eynde

Citation

Vladimir Dobričić, Dragana Vukadinović, Jelena Grahovac, Olivera Čudina, Design of new telmisartan analogues without AT1 receptor antagonistic activity, in Proceedings of 7th International Electronic Conference on Medicinal Chemistry, 1 November–30 November 2021, MDPI: Basel, Switzerland, doi: 10.3390/ECMC2021-11459

Facebook

Twitter

Design of new telmisartan analogues without AT1 receptor antagonistic activity

Dragana Vukadinović ¹

Jelena Grahovac ²

Olivera Čudina ¹

Vladimir Dobričić ¹

1. Department of Pharmaceutical Chemistry, University of Belgrade - Faculty of Pharmacy, Belgrade, Serbia

2. Department of Experimental Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia

Abstract

Keywords

antitumor activity

FRED software

molecular docking

telmisartan derivatives

Poster

Poster - Vladimir Dobricic.pdf